SIGMAR1 and Cognitive impairment: The results of this study not only confirmed the cellular mechanisms of astrocytic Sig-1R activation ameliorating complement-mediated synapse deficits and cognitive disorder in the pathogenesis of DACD, but also provided evidence for ideal clinical translational treatment using Sig-1R agonists.